# Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).

> clinical trial · VERIFIED · 2026-06-25

Status: COMPLETED · Sponsor: AstraZeneca · Condition: Chronic Obstructive Pulmonary Disease (COPD)

- Company: AstraZeneca
- Sector: pharma
- Primary source: https://clinicaltrials.gov/study/NCT05742802

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.